Better treatments improve survival of CHD patients.
Ninivaggi
Loretta
L
Department of Medicine, Endocrinology Section, Jersey Shore University Medical Center, Neptune, NJ, USA.
D000293:Adolescent; D000328:Adult; D000359:Aftercare / Q000458:organization & administration; D006585:Altretamine; D002648:Child; D006301:Health Services Needs and Demand; D006330:Heart Defects, Congenital / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D008134:Long-Term Care / Q000458:organization & administration; D009720:Nurse Clinicians / Q000458:organization & administration; D009722:Nurse Practitioners / Q000458:organization & administration; D024802:Nurse's Role; D009730:Nursing Assessment; D010348:Patient Care Team / Q000458:organization & administration; D010353:Patient Education as Topic; D015995:Prevalence; D012944:Social Support; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D006585:Altretamine